In this study we report that human phosphatidylethanolamine-binding protein (hPBP) facilitates heterotrimeric G protein-coupled signaling. In Xenopus laevis oocytes, coexpression of hPBP with human opioid receptor, human ␦ opioid receptor, or human somatostatin receptor 2 evoked an agonist-induced increase in potassium conductance of G protein-activated inwardly rectifying potassium channels. This activation of heterotrimeric G protein signaling in oocytes could also be elicited by injection of bacterially overexpressed and purified hPBP. Stimulatory effect was pertussis toxinsensitive and present even in the absence of coexpressed receptors. Additionally, an increase in G protein-mediated inhibition of adenylate cyclase activity, measured by the inhibition of forskolin-mediated cAMP accumulation, could be detected in HEK293 and NIH3T3 cells after expression of hPBP and in Xenopus oocytes after injection of hPBP. As 
In this study we report that human phosphatidylethanolamine-binding protein (hPBP) facilitates heterotrimeric G protein-coupled signaling. In Xenopus laevis oocytes, coexpression of hPBP with human opioid receptor, human ␦ opioid receptor, or human somatostatin receptor 2 evoked an agonist-induced increase in potassium conductance of G protein-activated inwardly rectifying potassium channels. This activation of heterotrimeric G protein signaling in oocytes could also be elicited by injection of bacterially overexpressed and purified hPBP. Stimulatory effect was pertussis toxinsensitive and present even in the absence of coexpressed receptors. Additionally, an increase in G protein-mediated inhibition of adenylate cyclase activity, measured by the inhibition of forskolin-mediated cAMP accumulation, could be detected in HEK293 and NIH3T3 cells after expression of hPBP and in Xenopus oocytes after injection of hPBP. As Phosphatidylethanolamine-binding proteins (PBPs) 1 comprise a family of polypeptides found to be present in various plant and animal organisms like Arabidopsis (1-3), tomato (1) (2) (3) , tobacco (1) (2) (3) , Saccharomyces cerevisiae (4), Onchocerca volvulus (5) , Caenorhabditis elegans (6) , and Drosophila melanogaster (7) , as well as in mammals (human, rat, mouse, and bovine) (8, 9) .
Although a variety of biological roles have previously been described, the cellular and molecular function of species-specific PBPs remains unclear. The plant PBP orthologues TER-MINAL FLOWER 1, SELF-PRUNING, and CENTRORADIA-LIS were shown to be involved in the regulation of flowering signaling and meristem growth (1) (2) (3) . In nematodes PBPs were found to be part of secreted cell-surface proteins and proposed to function as a protective mechanism against host immunological response (10) . The Drosophila PBP homologues were decribed as putative odorant-binding effector molecules, expressed in different subsets of olfactory hairs (11) . The human and rat brain PBPs act as precursor proteins for the hippocampal cholinergic neurostimulating peptide. This undecapeptide is released of the N-terminal region of PBP (12) and stimulates the acetylcholine synthesis and the cholinergic activity in rat medial septal nuclei (13) . Although PBP expression could be detected in all mammalian tissues tested (14, 15) , particularly high levels were found in spermatids (16), brain oligodendrocytes, Purkinje cells, and specific cortical and hippocampal neuronal cell layers (15, 17) . Some studies support the hypothesis that PBPs are involved in cell-signaling machinery. The S. cerevisiae PBP orthologue TFS1 (for TWENTY-FIVE SUP-PRESSOR 1) was demonstrated to act as a dose-dependent suppressor of CDC25 mutations (4). CDC25 acts as a GTP/GTP exchange factor for Ras and is implicated in Ras activation (18 -20) . In contrast human RKIP (for Raf kinase inhibitor protein), which is identical to hPBP, has been characterized as an inhibitor of Ras-mediated signaling cascade and AP1-dependent transcription (21) . Analysis of the family of PBPs revealed high structural homology between PBPs from different species (22) (23) (24) . Mammalian PBPs consist of 187 amino acids and show a significant degree in sequence similarity (12) . The central region of these proteins constituted by residues 60 -126 appears to be best conserved and contains a region believed to play an essential role in PBP function and to be responsible for binding to G proteins (25) . In fact, bovine PBP was shown to associate with small GTP-binding proteins but failed to bind GTPs themselves (26) . To date, known data about PBPs implicate an involvement in multiple signaling mechanisms (22, 23, 25) .
Interestingly, the rat PBP homologue could be isolated by morphine affinity chromatography from rat brain membranes, suggesting an association with the G protein-coupled opioid receptor (MOR) (27) . The postulated association of PBP with MOR prompted us to test whether hPBP is involved in receptor-mediated heterotrimeric G protein signaling. In the present work we investigated the influence of human PBP on G protein signaling mediated by hMOR and other G protein-coupled receptors (GPCRs) (human ␦ opioid receptor, hDOR; human somatostatin receptor, hSSTR2) in Xenopus laevis as well as in HEK293 and NIH3T3 cells.
EXPERIMENTAL PROCEDURES

Materials-[
35 S]GTP␥S (specific activity, 1300 Ci/mmol) was obtained from PerkinElmer Life Sciences. GTP␥S, GDP, HEPES, isopropyl-1-thio-␤-D-galactopyranoside, ampicillin, kanamycin, puromycin, polyethylenimine, acrylamide, bisacrylamide, TEMED, and ammonium peroxodisulfate were from Sigma (Deisenhofen, Germany). Nitrocellulose filters (NC45) were from Serva (Heidelberg, Germany). DAMGO, DADLE, octreotide, and naloxone were from Tocris (Biotrend, Germany). Morphine was from Synopharm (Barsbuettel, Germany). PTX and rat recombinant G␣ i1 was from Calbiochem-Novabiochem GmbH (Schwalbach, Germany). Materials required for gel electrophoresis were from Bio-Rad (Muenchen, Germany). Female X. laevis were from Nasco (Fort Atkinson, WI). Two-electrode voltage clamp (TEVC) amplifier (Turbo TEC-05), breakout box, and perfusion system were from Polder electronics (Tamm, Germany). Buffers and salts were from Sigma and Merck; cAMP radioimmunoassay kit was from Amersham Pharmacia Biotech (Braunschweig, Germany). Glass capillaries (Kwikfil™ TW 150-F-3) for microinjection in oocytes and reference electrodes (Flexref) for TEVC were from World Precision Instruments (Sarasota, FL). Borosilicate glass capillaries for TEVC were from Hilgenberg (Malsfeld, Germany), and clamp electrodes were produced using a DMZ-Universal Puller (Zeitz Instruments, Germany). Micromanipulator (DC3001R) and electronic micromanipulator controller (MS 314) were from World Precision Instruments. Geneticin (G-418), agarose, bactotryptone, yeast extract, and agar were from Life Technologies, Inc. mMessage mMachine ® kit for synthesis of capped RNA transcripts was from Ambion. cDNA for hPBP (cloned in pT7/T3) was kindly provided by Prof. Rommelspacher (Benjamin Franklin University, Berlin, Germany), and hPBP cDNA was subcloned into pcDNA3.1(Ϫ) (pcDNA/hPBP) for stable expression in cells. rMOR1 cDNA was a gift from Prof. Lei Yu, and cDNAs for rMOR1 and rK ir 3.4 (subcloned in pcDNA3.1; Invitrogen) were described previously (28, 29) . For coexpression experiments, cDNA of rMOR1 was subcloned into expression plasmid pEAK 10 (Edge BioSystems) (pEAK10/rMOR1). H. A. Lester (Pasadena, CA) kindly provided rKir3.1 expression plasmid. hDOR expression plasmid was kindly provided by P. Mayer (Magdeburg, Germany), and hSSTR2 expression plasmid was from Novartis (Basel, Switzerland). HIS⅐BIND ® Quick 900 cartridges, bacterial strain BCL1(DE3), and inducible expression plasmid pET28a(ϩ) were from Novagen (Schwalbach, Germany).
Oocyte Preparation, RNA and Protein Injection, Expression of Receptors, hPBP, and the G Protein Inwardly Rectifying Potassium Channels-Preparation and culture of oocytes and cRNA preparation have been described previously (28) . Oocytes were injected with 50 nl containing 0.5 ng each of rK ir 3.1 and rK ir 3.4 cRNA, and 1 ng of receptor cRNA, 5 ng of hPBP cRNA, or both receptor and hPBP cRNA. Oocytes were incubated for 2-4 days at 18°C in ND96 (96 mM NaCl, 2.0 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2, 5 mM HEPES) supplemented with 5% fetal bovine serum, 2.5 mM sodium pyruvate, 100 units/ml penicillin, and 100 g/ml streptomycin. To generate capped mRNA for injection, mMessage mMachine ® capped RNA transcription kit (Ambion) was used. 50 nl (10 ng) of hPBP were injected per oocyte.
TEVC of X. laevis Oocytes-The method was performed as described previously (28, 29) . Data were analyzed with Eggworks software (Polder Electronics, Tamm, Germany). Clamped oocytes were superfused with either ND96, with a moderate potassium solution (K16: 82 mM NaCl, 16 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 ) with K16 containing receptor-specific agonist (1 M) or K16/BaCl 2 solution (K16 with 300 M BaCl 2 ) (see scheme in Fig. 1) . PTX experiments were performed by incubating oocytes with 1 g/ml pertussis toxin for ϳ18 h. Endogenous Ca 2ϩ release-activated Cl Ϫ current (I Cl1 ), which has an outwardly rectifying steady state current-voltage relationship (30, 31) was measured in ND96 at positive membrane potentials. Oocytes were clamped at Ϫ80 mV and stepped to ϩ40 mV for 500 ms every 3 s to monitor I Cl1 . Increase in current I Cl1 after injection of either CaCl 2 , GTP␥S, or hPBP (50 nl/oocyte each) was displayed as ⌬I Cl1 (see Fig. 6 ).
Cell Culture, Cell Transfections, and Generation of Stable Cell Lines-For generation of stable NIH3T3 cells expressing hPBP or HEK293 cells expressing rMOR1 or rMOR1 and hPBP, cells were transfected according to protocol described previously (29) . Selection of stable clones was performed by addition of either 500 g/ml Geneticin (pcDNA3.1/hPBP) or 1 g/ml puromycin (pEAK10/rMOR1). For coexpression of rMOR1 and hPBP in HEK293 cells, stable rMOR1-expressing clones were transfected with pcDNA3.1/hPBP and cells selected with Geneticin and puromycin. Sequences of cloned inserts were confirmed by DNA sequencing. Control NIH3T3 cells were transfected with pcDNA3.1(Ϫ) (without cloned insert).
[ 35 
S]GTP␥S Binding to HEK293, NIH3T3 Cell Membranes, and Recombinant G␣ i1 -[
35 S]GTP␥S binding was performed as described previously (29) . Stock [ at 30°C in 50 l of HEPES buffer (pH 7.9, 25 mM MgCl 2 , 100 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol) supplemented with 12.5 ng of G␣ i1 or with G␣ i1 and 100 ng of His-hPBP. Reaction was stopped by filtration on nitrocellulose filters at indicated time points and filters washed five times with ice-cold stop buffer (25 mM Tris-HCl, 100 mM NaCl, 25 mM MgCl 2 , pH 7.5). Bound radioactivity was determined by scintillation counting.
Measurements of cAMP Levels-1.5 ϫ 10 5 cells were seeded in 22-mm 12-well dishes with Dulbecco's modified Eagle's medium Nut-F12 medium containing 10% fetal calf serum. On the day of assay, media were removed from the individual wells and were replaced with 0.5 ml of serum-free medium containing 25 M forskolin or a combination of forskolin (25 M) and DAMGO (1 M). The cells were then incubated at 37°C for 15 min. The reaction was terminated by removing the medium and sonicating the cells in 1 ml of ice-cold HCl/EtOH (1 volume of 1 N HCl/100 volumes of EtOH). After centrifugation, the supernatant was evaporated, the residue dissolved in TE buffer and cAMP content measured. X. laevis oocytes were incubated in ND96 containing 20 M isobutylmethylxanthine for 20 min and then injected with His-hPBP and incubated for additional 20 min. Buffer was rapidly aspirated, and oocytes were sonicated and assayed for cAMP content as described above.
Generation and Isolation of His-tagged hPBP (His-hPBP)-A NdeIEcoRI DNA fragment, containing the hPBP reading frame, was generated from pT7/T3(hPBP) by polymerase chain reaction mutagenesis and subcloned into pET28a(ϩ). Bacterial strain BCL1(DE3) was transformed with pET28a(ϩ)(hPBP). Cloned sequence was proofed by sequencing. 100 ml of LB medium supplemented with glucose (1% final concentration) were inoculated and grown to an A 595 nm of 0.6. Cells were induced with 1 mM isopropyl-1-thio-␤-D-galactopyranoside and harvested 4 h after induction by centrifugation according to the Novagen protocol. Cell pellets were resuspended in ice-cold HIS⅐BIND ® buffer (500 mM NaCl, 25 mM HEPES, 5 mM imidazole, pH 7.9) and sonicated. Purification of His-tagged hPBP with His⅐BIND ® Quick 900 cartridges was performed according to Novagen's protocol and elution buffer (500 mM NaCL, 25 mM HEPES, 1 M imidazole) was used to elute hPBP. A 4-ml sample was further dialyzed five times in 2 liters of hPBP storage buffer (100 mM, 25 mM HEPES, pH 7.9). Protein concentration was determined, and aliquoted stocks (200 ng/l) were frozen (Ϫ70°C) in storage buffer.
RESULTS
Stimulation of G Protein Inwardly Rectifying Potassium
Channel K ir Conductance in Xenopus Oocytes by hPBP-As reported previously, superfusion of oocytes expressing G protein-coupled inwardly rectifying potassium channels (rK ir 3.1; rK ir 3.4) with potassium solution led to an increase in potassium conductance, that could be blocked by BaCl 2 (28, 29) . This basal channel-mediated current (I Kir-basal ) could be further enhanced (I Kir-activated ) by application of a specific opioid agonist (e.g. DAMGO or morphine) to oocytes coexpressing human opioid receptor (hMOR) (see scheme in Fig. 1) . In this study we tested influence of hPBP on basal and agonist-induced K ir currents. Coexpression of hPBP, hMOR and K ir channels resulted in a significant enhancement of both I Kir-basal (ϳ1.3-fold) and I Kir-activated (ϳ1.6-fold) compared with oocytes expressing hMOR and K ir channels ( Fig. 2A) . In oocytes coexpressing hPBP and K ir channels, only no effect on I Kir-basal could be detected (data not shown). In addition, the EC 50 values were not found to be significantly different for morphine-treated hMOR-and hMOR/PBP-expressing oocytes (ϳ52 and ϳ63 nM, respectively) (Fig. 2B) . To evaluate whether the stimulatory effect on the K ir channel activity is restricted to the presence of hMOR, we coexpressed hPBP with either hDOR or hSSTR2. Similar to hMOR, the agonist-induced current I Kir-activated in both hSSTR2-and hDOR-expressing oocytes was significantly increased after stimulation with a specific agonist (hSSTR2: octreotide, 1 M; hDOR: DADLE, 1 M) when hPBP was coexpressed (Fig. 2C) . In case of hSSTR2, receptor-mediated current (I Kir-activated ) was stimulated less efficiently (ϳ1.2-fold) than hDOR-mediated I Kir-activated (ϳ2-fold). Although the extent of stimulation differed, these data indicate that the effect of hPBP on G protein-dependent coupling of receptors to K ir is not only restricted to the presence of the opioid receptor.
Stimulation of K ir -mediated Conductance and Reduction of cAMP Level in X. laevis Oocytes by Injection of His-hPBP Pro-
tein-To test whether the influence of hPBP on K ir -mediated conductance is directly mediated by the presence of hPBP and not due to long term expression-induced intracellular changes, purified histidine-tagged hPBP was injected in X. laevis oocytes, expressing either K ir channels and hMOR or K ir channels only. Control oocytes were injected with heat-inactivated hPBP. Changes in I Kir-basal and/or I Kir-activated were measured 1-2 min after injection. PBP injection in hMOR-expressing oocytes resulted in an significant enhancement of both I Kir-basal and I Kir-activated as described previously in coexpression experiments. In contrast to the hPBP coexpression experiments, injection of His-hPBP was more potent to stimulate I Kir-basal (1.6-fold) than I Kir-activated (1.3-fold) (Fig. 3A) . In addition, hPBP injection could directly stimulate basal K ir conductance (I Kir-basal ) ϳ2.2-fold, even in the absence of a coexpressed receptor (Fig. 3B) . This effect could be blocked by PTX (60% inhibition). A comparable inhibition could be detected in PTXtreated DAMGO-stimulated oocytes expressing hMOR (85% inhibition), indicating that hPBP could stimulate K ir channels and G protein coupling of hMOR to K ir channels in a direct and acute G i/o protein-dependent fashion (Fig. 3C) . In order to evaluate the potency of hPBP to influence other G protein-coupled systems (e.g. adenylate cyclase), cAMP levels of oocytes injected with hPBP were compared with that of mock-injected ones. As cAMP levels varied in X. laevis oocytes isolated from different frogs (1.3-2.9 pmol of cAMP), data from independent experiments were normalized. Injection of hPBP led to an ϳ38% reduction of the intracellular cAMP level (Fig. 3D) . The results 
FIG. 2. hPBP expression stimulates K ir conductance in
Xenopus oocytes. Oocytes were superfused with saline buffer containing 16 mM KCl to elicit a current flow through the inwardly rectifying potassium (K ir ) channels (data are shown as mean Ϯ S.E.). A, hPBP coexpression with hMOR significantly enhances basal K ir conductance (I Kir-basal ) ϳ1.35-fold and agonist-induced (morphine, 1 M) receptormediated K ir conductance (I Kir-activated ) ϳ1.62-fold. Currents are in nA (n ϭ 5 oocytes; *, p Ͻ 0.05; **: p Ͻ 0.01, unpaired two-tailed t test). B, dose-dependent hMOR activation by morphine was constructed by determination of I Kir-activated under increasing concentration of agonist. The response to each dose of morphine was normalized as the percentage of maximum response of oocytes expressing hMOR and K ir channels only. As shown previously, coexpression of hPBP resulted in a significant stimulation of I Kir-activated . EC 50 value of morphine was not found to be significantly changed in hPBP-expressing oocytes compared those expressing hMOR and K ir channels only (ϳ52 nM Ϯ 17.5 (hMOR) versus ϳ63 nM Ϯ 12.5 (hMOR/hPBP); mean Ϯ S.E., n ϭ 4 -6 oocytes; p Յ 0.05). C, oocytes were injected with 1 ng of cRNA encoding hSSTR2 or hDOR and K ir cRNA as described under "Experimental Procedures." Oocytes expressing hSSTR2 or hDOR were stimulated, as shown in Fig. 1 , with either 1 M octreotide (SSTR2 agonist) or 1 M DADLE (hDOR agonist). Agonist-induced currents (I Kir-activated ) measured in oocytes expressing hPBP were normalized as the percentage of current response detected in oocytes expressing receptor and K ir channels only. hPBP coexpression led to a significant enhancement of agonist-induced K ir conductance (I Kir-activated ). hPBP showed a higher potency to stimulate I Kir-activated. in hDOR-expressing oocytes (ϳ2-fold) than in hSSTR2-expressing ones (ϳ1.25-fold) (data are mean Ϯ S.E., n ϭ 5 oocytes; *, p Յ 0.05; **, p Յ 0.01, two-tailed unpaired t test).
obtained suggest that hPBP injection may influence adenylate cyclase activity.
hPBP-mediated Reduction of cAMP Level in HEK293 and NIH3T3 Cells-In order to specify hPBP-mediated cAMP reduction, forskolin-induced stimulation of adenylate cyclase was studied in HEK293 and NIH3T3 cells overexpressing hPBP, rMOR1, or both hPBP and rMOR1. Forskolin stimulation of HEK293 cells stably expressing rat opioid receptor (rMOR1) and hPBP resulted in a significant reduction in cAMP level (55% of control) compared with control HEK293 cells expressing rMOR1 only (Fig. 4A) . Basal cAMP content was not found to be significantly different. In addition, coexpression of hPBP and rMOR1 also led to a significantly enhanced DAMGO (1 M)-mediated reduction of forskolin-induced cAMP level compared with rMOR1-expressing cells (4.5 and 14% for rMOR1/ hPBP-and rMOR1-expressing cells, respectively). Thus, as shown for G protein-coupled K ir conductance in Xenopus oocytes, expression of hPBP in HEK293 significantly amplified receptor-mediated G protein-coupled signaling of rMOR1, indicating a stimulatory effect of hPBP on opioid receptor-mediated inhibition of adenylate cyclase. Moreover, in mouse NIH3T3 cells stably expressing hPBP (Fig. 4B) , stimulation of adenylate cyclase with forskolin led to an significant decrease of cAMP levels (ϳ60%) compared with pcDNA3.1-transfected control cells, indicating a direct involvement of hPBP in reduction of adenylate cyclase-mediated cAMP formation. Basal cAMP levels were not significantly changed in both cell lines. A, injection by His-hPBP led to a significant stimulation of I Kir-basal (left side of figure; 165% of control, n ϭ 4; **, p Յ 0.01, unpaired two-tailed t test). I Kir-activated was also enhanced significantly but to a lower extent (right side of the figure; 134% of control; n ϭ 4 oocytes; p Յ 0.05, unpaired two-tailed t test). B, oocytes expressing only K ir channels were injected with His-hPBP as described above. His-hPBP stimulated basal K ir conductance significantly (ϳ 220% of control, n ϭ 4; ***, p Յ 0.001, unpaired two-tailed t test). C, oocytes expressing either hMOR and K ir channels (i) or K ir channels (ii) only were treated with PTX (1 g/ml) for 18 h and either stimulated with DAMGO (i) or injected with His-hPBP (ii) as described above. His-hPBP-stimulated K ir conductance as well as DAMGO-stimulated K ir conductance were found to be significantly reduced compared with control maximum response (14% (i) and 33% (ii) of control, n ϭ 4 -5; ***, p Յ 0.001, unpaired two-tailed t test). D, X. laevis oocytes were injected with 10 ng of His-hPBP or mock-injected with heat-inactivated His-hPBP. After 20 min of incubation, cells were lysed and assayed for cAMP content. Mock-injected oocytes from one experiment were normalized as 100% (control), and His-hPBP injectioninduced changes of cAMP level were displayed as percentage of control. Oocytes injected with active His-hPBP showed significant lower levels of cAMP than mock-injected ones (ϳ62% of control; **, p Յ 0.01, unpaired two-tailed t test). Data shown are from four independent experiments (5 oocytes/experiment, performed in duplicate). All data are shown as mean Ϯ S.E.
Stimulation of [ 35 S]GTP␥S Binding to Cell Membranes by hPBP-PBPs
FIG. 3.
Injection of hPBP protein in hMOR/K ir and K ir -expressing oocytes stimulates K ir conductance and reduces cAMP levels. His-hPBP was purified (see "Experimental Procedures"), and oocytes expressing hMOR and K ir channels were injected with 50 nl (10 ng) of His-hPBP in saline buffer. Control oocytes were injected with heat-inactivated (95°C, 10 min) His-hPBP. At 1-2 min after injection, I Kir-activated and I Kir-basal were determined as described previously. Mean hPBP Facilitates G Protein Signalingnot altered by hPBP at given temperatures (data not shown). This stimulatory effect on [
35 S]GTP␥S binding could be also detected on membranes of untransfected HEK293 cell if recombinant His-hPBP was used for stimulation. His-hPBP dosedependently stimulated specific [
35 S]GTP␥S binding with an apparent EC 50 of 3.6 nM (Fig. 5B) . Stimulation of membranebound G proteins is obviously due to binding to heterotrimeric G i proteins, as hPBP facilitated GTP binding to soluble rat G␣ i1 in vitro in a time-dependent manner (Fig. 5C) .
hPBP Mediates Stimulation of a Ca 2ϩ Release-activated Chloride Current-G q -coupled receptors have been shown to stimulate a Ca 2ϩ -activated chloride current in Xenopus oocytes (33) . Increases in cytosolic Ca 2ϩ levels result from phospholipase C/inositol trisphosphate-dependent Ca 2ϩ release from internal stores and Ca 2ϩ influx from the extracellular medium. To test whether hPBP could also stimulate PLC-dependent pathways, we tested effects of hPBP injection in oocytes on the Ca 2ϩ release-activated outwardly rectifying Cl Ϫ current (I Cl1 ) (Fig. 6, A and B) . GTP␥S injection as well as CaCl 2 injection (60 pmol) resulted in a significant stimulation of I Cl1 (maximum induced change in current ⌬I Cl1 : GTP␥S, ϳ1100 nA; CaCl 2, ϳ296 nA). The CaCl 2 -mediated effect could be mimicked by injection of 10 ng/oocyte hPBP (⌬I Cl1 ϳ 210 nA), indicating that hPBP leads to an release of Ca 2ϩ from internal stores.
DISCUSSION
In previous studies PBPs were shown to affect regulation of cellular signaling and growth. They were found to associate with G proteins but failed to bind GTP themselves (26) . In the   FIG. 4 . hPBP lowers cAMP formation in HEK293 and NIH3T3 cells. A, the figure shows changes of basal, forskolin-, and forskolin/ DAMGO-induced cAMP levels in rMOR1-and rMOR1/hPBP-expressing HEK293 cells. Forskolin-induced cAMP levels of HEK293 cells expressing rMOR1 were normalized and set as 100%. hPBP coexpression led to a significant reduction (55% of control) of forskolin-induced cAMP level compared with rMOR1-expressing HEK293. Basal cAMP levels were not significantly affected. Furthermore, rMOR1/hPBP-expressing cells showed a significant and more potent DAMGO-induced decrease in cAMP levels (4.5% of forskolin-stimulated rMOR1/hPBP cells) than rMOR1-expressing cells (14% of forskolin-stimulated rMOR1 cells). Data were obtained from two independent experiments (n ϭ 3 per experiment; *, p Յ 0.05, two-tailed t test). B) Forskolin-induced cAMP formation in mock-transfected (pcDNA3 vector-transfected) NIH3T3 cells was normalized and set as 100%. hPBP-expressing cells revealed a significantly reduced cAMP level after forskolin stimulation (ϳ40% of control). Basal cAMP levels were not significantly different. Data shown were from three independent experiments (n ϭ 2 per experiment; *, p Յ 0.05, two-tailed t test). hPBP Facilitates G Protein Signalingpresent study we demonstrate the involvement of hPBP in heterotrimeric G protein-dependent signaling.
According to oocyte studies, hPBP acted like an enhancer of G protein-coupled receptor-mediated activation of inwardly rectifying K ir 3 channels. The K ir -mediated potassium conductance is stimulated directly by free ␤-␥ subunits of heterotrimeric G proteins (34, 35) . Therefore, the observed effect of an enhanced conductance in the presence of hPBP might be explained by an increased liberation of free ␤-␥ subunits from heterotrimeric G proteins, resulting from a direct interaction of hPBP with heterotrimeric G proteins themselves. This hypothesis is supported by the observation that stimulation was not restricted to the presence and stimulation of a specific GPCR and that direct hPBP injection resulted in a comparable PTXsensitive stimulation even in the absence of coexpressed receptors. As hPBP mimicked the effect of an activated G i /G o protein, it could be assumed that hPBP activates heterotrimeric G proteins. Such an activity would further explain the ability of hPBP to reduce cAMP levels in oocytes as well as HEK293 and NIH3T3 cells, since adenylate cyclase activity is inhibited by activated GTP-bound G i /G o ␣ subunits. In addition hPBP also seems to be involved in other G protein-dependent pathways, as hPBP was able to elicit a stimulatory effect on the Ca 2ϩ release-activated Cl Ϫ current in oocytes comparable to that seen after CaCl 2 injection. Although PLC-mediated Ca 2ϩ release in oocytes is G o -dependent, it is important to note that receptors that couple to G q in native tissue regularly couple to Xenopus G o. In agreement with this finding, we could show that the presence of hPBP stimulates [
35 S]GTP␥S binding to membranes in a dose-dependent manner, indicating that hPBP led to an activation of membrane-bound G proteins. PBP is a major protein component (ϳ18%) in detergent extracts and plasma membrane preparations of rat epididymal spermatozoa (36) . Analysis of overall protein and mRNA expression in different rat tissues (15) displayed comparable amounts of hPBP in epididymis, liver, adrenal gland, and brain. PBP is predominantly expressed at highest levels in distinct cell types and specific brain regions (37) including neuronal cell layers. The high efficiency (EC 50 values ϳ3.6 nM; ϳ8.3 ng (hPBP)/20 g (membrane protein)) of hPBP mediated [
35 S]GTP␥S binding to membranes strikingly indicate that hPBP would play a role in membrane-associated heterotrimeric G protein-coupled signaling in this cell region.
In recent years, several proteins regulating G protein activity have been described. GDP dissociation inhibitors were shown to act as negative modulators of G protein activity by inhibiting GDP release from the G protein (38 -40) . GTPaseactivating proteins accelerate GTPase activity on G proteins, thus leading to a GDP-bound inactive G protein (41, 42 Ϫ conductance was measured as outwardly rectifying current at positive membrane potential (ϩ40 mV). A, typical current traces corresponding to the Ϫ80 mV/ϩ40 mV pulse combination after mock injection (1) or injection of 60 pmol of CaCl 2 (2), 10 ng of His-hPBP (3), or 50 pmol of GTP␥S (4) . Voltage protocol is shown at the top (see also "Experimental Procedures"). B, change in chloride current (⌬I Cl1 ) after injection (data: mean Ϯ S.E., n ϭ 5-8 oocytes; *, p Յ 0.05; **, p Յ 0.01, unpaired two-tailed t test). GDP, resulting in an active GTP-bound G protein (19, 43) . Although the mechanism of the activation of heterotrimeric G proteins by hPBP is unclear, our observations make it reasonable to speculate that hPBP activates heterotrimeric G protein coupling by elevating GDP/GTP exchange on G␣ subunits, as described for GTP exchange factors. This is in good agreement with our data showing that hPBP stimulates GTP binding to soluble G␣ i1 subunit in vitro.
Surprisingly, comparison between injection and expression experiments in oocytes further revealed that injection of recombinant hPBP more potently stimulated basal K ir conductance than receptor-mediated K ir conductance; moreover, in the absence of coexpressed receptors, hPBP injection resulted in a GPCR-like PTX-sensitive stimulation. These results suggest that, under given circumstances, injected hPBP lacking eukaryotic posttranslational modifications represents a functional activated form of the protein and that intracellular activity of expressed hPBP is regulated in the presence and after stimulation of given GPCRs. In the absence of such receptors, hPBP coexpression in oocytes had no effect on K ir channels (data not shown). For an interaction with the membrane-bound heterotrimeric G protein, it is necessary that hPBP is located near the plasma membrane. As PBPs were mostly found to be cytosolic, regulation of both the hPBP potency to bind to phospholipids like phosphatidylethanolamine and phosphatidylcholine (26) and the targeting of PBPs to the cell membrane could lead to a modulation of the activity of heterotrimeric G proteins. Consistent with this model, Yeung and co-workers (21, 44) reported that both Raf1 and mitogen-activated protein/ extracellular signal-regulated kinase kinase bind to a highly conserved region of hPBP described as phosphatidylethanolamine-binding domain (see Fig. 7 ; accession no. PS01220) and that targeting of hPBP to the cell membrane occurred after mitogenic stimulation (21, 44) .
In this context it is interesting to note that a second highly conserved region (proline 112 to tyrosine 125) described as a putative nucleotide binding domain within hPBP overlaps with an amino acid region (valine 107 to leucine 123) that shares a significant homology (94%) to a sequence pattern also known as G protein-coupled receptor signature (Fig. 7) (22, 25) . The 17-amino acid consensus sequence signature (Prosite accession no. PS00237, Fig. 7C ) is found in the second intracellular loop of GPCRs and contains a conserved acidic-arginine-aromatic triplet (arginine conserved to 100%) shown to be important for interaction and coupling of GPCRs to heterotrimeric G proteins (45, 46) . As shown by amino acid sequence analysis/alignment (Fig. 7B) , this signature as well as the arginine (signature position 13) is also highly conserved within specific PBPs. Although a proline present in PBP sequences is not found in the consensus G protein-coupled receptor signature (signature position 6), its high conservation within most animal and plant PBPs (data not shown) indicates an essential role in PBP function. This suggests that the mechanism of hPBP-mediated effects could be closely related to that elicited by GPCRs. The nature of this mechanism is currently under investigation. The identification of hPBP as a novel modulator involved in heterotrimeric G protein signaling could offer new insights into PBP function and regulation of receptor-dependent heterotrimeric G protein-coupled signaling.
